Dr. Jai Man Lee is a pharmacist who is specialized in Oncology in New York, New York. Patients can reach him at 530 East 74th Street, New York or contact him on 646-608-1725. Active license number of Dr. Jai Man Lee is 058502 for Oncology in New York. Dr. Jai Man Lee is a licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.
Complete Profile:
Dr. Jai Man Lee speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for enquiries.
Name:
Dr. Jai Man Lee
Specialization:
Oncology
Gender:
Male
Location:
530 East 74th Street, New York, New York, 10021
Phone:
646-608-1725
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of Dr. Jai Man Lee are as mentioned below.
NPI Number:
1861014946
NPI Enumeration Date:
12 May, 2020
NPI Last Update On:
12 May, 2020
Medical Licenses:
Pharmacists can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Dr. Jai Man Lee are as mentioned below.
Specialization
License Number
State
Status
Oncology
058502
New York
Primary
Pharmacist
28RI03380300
New Jersey
Secondary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
368 Abbott Ave, Ridgefield, New Jersey
Zip:
07657-2502
Phone Number:
201-681-2321
Fax Number:
--
Patients can reach Dr. Jai Man Lee at 530 East 74th Street, New York, New York or can call on phone at 646-608-1725.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.